Sun Pharma's Unloxcyt: Skin Cancer Drug Hits 50% Response Rate

Health

DeluluDelulu

Sun Pharma's Unloxcyt: Skin Cancer Drug Hits 50% Response Rate

Okay, squad, gather ‘round! Sun Pharma just served up some serious news at ASCO about their skin cancer fighter, Unloxcyt. With a jaw-dropping 50% response rate after 31 months, this drug is basically the superhero we didn’t know we needed! And side effects? Only 34% of peeps had 'em! This is the glow-up we’ve all been waiting for!